SCGB1D2 Antibody Cat. No.: 57-276

SCGB1D2 Antibody

Specifications

HOST SPECIES: Rabbit

SPECIES REACTIVITY: Human

This SCGB1D2 antibody is generated from rabbits immunized with a KLH conjugated IMMUNOGEN: synthetic peptide between 22-50 amino acids from the Central region of human SCGB1D2.

TESTED APPLICATIONS: WB

APPLICATIONS: For WB starting dilution is: 1:1000

PREDICTED MOLECULAR 10 kDa WEIGHT:

Properties

This antibody is purified through a A column, followed by peptide affinity PURIFICATION: purification.

CLONALITY: Polyclonal

ISOTYPE: Rabbit Ig

CONJUGATE: Unconjugated

September 24, 2021 1 https://www.prosci-inc.com/scgb1d2-antibody-57-276.html PHYSICAL STATE: Liquid

BUFFER: Supplied in PBS with 0.09% (W/V) sodium azide.

CONCENTRATION: batch dependent

Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies STORAGE CONDITIONS: care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Additional Info

OFFICIAL SYMBOL: SCGB1D2

ALTERNATE NAMES: Secretoglobin family 1D member 2, Lipophilin-B, SCGB1D2, LIPHB, LPNB

ACCESSION NO.: O95969

GENE ID: 10647

USER NOTE: Optimal dilutions for each application to be determined by the researcher.

Background and References

The protein encoded by this is a member of the lipophilin subfamily, part of the uteroglobin superfamily, and is an ortholog of prostatein, the major secretory glycoprotein of the rat ventral prostate gland. Lipophilin gene products are widely expressed in normal tissues, especially in endocrine-responsive organs. Assuming that human lipophilins are the functional counterparts of prostatein, they may be BACKGROUND: transcriptionally regulated by steroid hormones, with the ability to bind androgens, other steroids and possibly bind and concentrate estramustine, a chemotherapeutic agent widely used for prostate cancer. Although the gene has been reported to be on 10, this sequence appears to be from a cluster of on that includes mammaglobin 2.

REFERENCES: 1) Sjodin, A., et al. Anticancer Res. 28 (3A), 1493-1498 (2008) :

2) Culleton, J., et al. Int. J. Cancer 120(5):1087-1092(2007)

3) Sjodin, A., et al. Acta Neuropathol. 109(4):381-386(2005)

4) Carter, D., et al. Clin. Cancer Res. 9(2):749-754(2003)

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.

September 24, 2021 2 https://www.prosci-inc.com/scgb1d2-antibody-57-276.html